首页 正文

[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma]

{{output}}
With the rapid development of systemic therapy for primary hepatocellular carcinoma, how to scientifically formulate subsequent treatment strategies following first-line treatment failure has become a key issue that urgently needs to be addressed in clinical p... ...